Remove Controlling Remove Manufacturing Remove Pharmaceutical
article thumbnail

Where’s Your Visitor?

The Receptionist

In your manufacturing facility, you likely have areas—such as receiving, production, and shipping—that are off-limits for certain personnel and visitors. Depending on what you produce, you may also have clean rooms, climate-controlled areas, or storage for hazardous materials.

article thumbnail

The Iatrogenic Gaze: How We Forgot That Psychiatry Could Be Harmful

Mad in America

Doctors became hypnotized by the appearance of “science”, even if the literature they consulted was essentially pharmaceutical advertising. Such optimism would be disappointed by dwindling pharmaceutical progress in the later half of the century. When medications did cause harm, the doctors were completely blind to it.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A kaleidoscope approach to leading: Five perspective shifts that can foster innovation

Work Life

In Tony’s work as a leadership coach, he worked with a pharmaceutical CEO who realized that her company’s long-term vision had become blurred. A manufacturing department head we worked with struggled with operational inefficiencies. We worked on refining her vision, focusing on sustainability and innovation.

article thumbnail

The Clinical, Social, and Cultural Harm of an Iatrogenic Psychiatry

Mad in America

In contrast, psychiatry can point to no treatment that is effective in a scientific sense (in other words, compared to a placebo control or the passage of time). In April 2002, JAMA published a randomized controlled trial (RCT) in which the placebo worked better than both the herb St. Antidepressants? between 1990 and 2019.”

Reporting 135
article thumbnail

Consumer-Focused Approaches Won't Curb Health Care Spending

Inside Workplace Wellness

In the fourth quarter of last year, health care surpassed retail and manufacturing to become the largest source of jobs in the United States. Putting pressure in one area to control costs is like squeezing a balloon--it increases the cost somewhere else. of the patients who use it. Prescription Drug Spending in the U.S.

article thumbnail

Critical Psychiatry Textbook, Chapter 16: Is There Any Future for Psychiatry? (Part Six)

Mad in America

Schatzberg has served as a consultant to or received honoraria from Abbott, Bristol-Myers Squibb, Corcept Therapeutics, Forest Laboratories, Janssen, Eli Lilly, Merck, Mitsubishi Pharmaceuticals, Organon, ParkeDavis, Pfizer, Pharmacia–Upjohn, Sanofi, Scirex, SmithKline Beecham, Solvay, and Wyeth–Ayerst. Make forced treatment unlawful.

article thumbnail

The American Journal of Psychiatry’s Answer to MIA: A Silence that Speaks Volumes

Mad in America

However, in the summer of 1990, the Prozac story started to come undone, and it was then that the pharmaceutical industry, in concert with its thought leaders from academic psychiatry, plotted the strategy that has successfully cowed the mainstream media ever since. But he spoke to the public from the pulpit of Harvard Medical School.

Reporting 135